Mechanism Comparison Factor CJC-1295 + Ipamorelin HGH (Somatropin) Approach Stimulates endogenous GH production Replaces GH with exogenous protein Pituitary involvement Required pituitary manufactures and releases GH Bypassed GH delivered directly Feedback loop Preserved somatostatin still regulates GH levels Suppressed exogenous GH downregulates natural production GH release pattern Pulsatile, mimics natural circadian rhythm Spike-and-decline, non-physiological Receptor targets GHRH-R (CJC-1295) + GHS-R1a (Ipamorelin) GH receptor directly (no pituitary signaling) Molecular size CJC-1295: 29 AA (~3,368 Da) / Ipamorelin: 5 AA (~712 Da) 191 amino acids (~22,124 Da) The Pituitary Feedback Question This is arguably the most important mechanistic difference for researchers to understand
They combine GLP-1 therapy with practical nutrition advice to promote lasting results
The medication is still binding to receptors, still activating pathways, but the intensity has dulled
(Just keep in mind: RBC testing is not available for all micronutrients, including vitamin D.) What your results actually mean (and why "normal" isn't always optimal) Once your blood is drawn, your levels are compared to a reference range of "normal" values for a nutrient to assess your status
Research from the SURMOUNT-4 trial showed that participants who discontinued tirzepatide regained roughly two-thirds of the weight theyd lost within one year
Most peptides degrade rapidly in the body, but BPC-157 remains active long enough to exert therapeutic effects
